Dar Zavain
Insider CIK 1852075 · RXRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-10-01 | 2026-10-02 | 4,607 | — | $0 | 245,371 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-07-01 | 2026-07-02 | 5,109 | — | $0 | 240,764 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-06-17 | 2026-06-22 | 88,424 | — | $0 | 235,655 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-04-01 | 2026-04-02 | 4,902 | — | $0 | 147,231 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-01-02 | 2026-01-06 | 3,571 | — | $0 | 142,329 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-10-01 | 2025-10-03 | 2,941 | — | $0 | 138,758 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-07-01 | 2025-07-03 | 2,924 | — | $0 | 135,817 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2025-06-18 | 2025-06-23 | 44,031 | — | $0 | 44,031 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-06-18 | 2025-06-23 | 22,016 | — | $0 | 132,893 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-04-01 | 2025-04-03 | 2,745 | — | $0 | 110,877 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-01-02 | 2025-01-06 | 1,907 | — | $0 | 108,132 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-10-01 | 2024-10-04 | 2,229 | — | $0 | 106,225 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-07-01 | 2024-07-03 | 1,843 | — | $0 | 103,996 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2024-06-03 | 2024-06-05 | 26,193 | — | $0 | 26,193 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-06-03 | 2024-06-05 | 13,097 | — | $0 | 102,153 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-04-01 | 2024-04-03 | 1,467 | — | $0 | 89,056 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-01-02 | 2024-01-04 | 1,393 | — | $0 | 55,216 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-12-14 | 2023-12-18 | 20,141 | $9.00 | $181.3K | 53,823 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-10-02 | 2023-10-04 | 1,920 | — | $0 | 73,964 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-07-03 | 2023-07-06 | 1,863 | — | $0 | 72,044 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2023-06-16 | 2023-06-21 | 25,224 | — | $0 | 25,224 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-06-16 | 2023-06-21 | 12,612 | — | $0 | 70,181 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-04-03 | 2023-04-05 | 1,996 | — | $0 | 22,561 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-04-03 | 2023-04-28 | 1,996 | — | $0 | 57,569 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2022-07-08 | 2022-07-12 | 2,420 | — | $0 | 20,565 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-06-14 | 2022-06-16 | 36,290 | — | $0 | 36,290 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-06-14 | 2022-06-16 | 18,145 | — | $0 | 18,145 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-12-07 | 2021-12-09 | 3,599 | — | $0 | 3,599 | SEC↗ |